SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-251786
Filing Date
2018-08-17
Accepted
2018-08-17 17:01:07
Documents
7
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d583971d10qa.htm 10-Q/A 40401
2 EX-10.1A d583971dex101a.htm EX-10.1A 123731
3 EX-10.1B d583971dex101b.htm EX-10.1B 32571
4 EX-10.2 d583971dex102.htm EX-10.2 187052
5 EX-10.3 d583971dex103.htm EX-10.3 1320870
6 EX-31.3 d583971dex313.htm EX-31.3 4228
7 EX-31.4 d583971dex314.htm EX-31.4 4242
  Complete submission text file 0001193125-18-251786.txt   1714264
Mailing Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927
Business Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927 011-353-1-236-2500
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35676 | Film No.: 181026376
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences